US politicians want federal funding to discover cost effectiveness of new drugs
AUTOR(ES)
Moynihan, Ray
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=196387Documentos Relacionados
- Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle
- Federal funding for comparative drug studies not in US budget
- Cost effectiveness of heart drugs varies widely, study shows
- New methods of analysing cost effectiveness
- Is a US analysis of cost-effectiveness in interventional cardiology relevant to a centrally funded health care system?